Bdprobetec Et Ct/Gc Amplified Dna Assay
Dna-Reagents, Neisseria. 510(k) K012351, from Becton, Dickinson & CO (Sparks, MD). Product code LSL, class 2.
As of Nov 21, 2026, K012351 is an FDA 510(k) held by Becton, Dickinson & CO, substantially equivalent on Sep 18, 2001 after 55 days, with no recalls tied to it in FDA's recall database.
- Review time: 55 days
- Recalls: 0
- Cited as a predicate by: 4 devices
The BDProbeTecâ„¢ ET Chlamydia trachomatis and Neisseria gonorrhoeae Amplified DNA Assays, when tested with the BDProbeTecâ„¢ ET System, use Strand Displacement Amplification (SDA) technology for the direct, qualitative detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA in endocervical swabs, male urethral swabs, and in female and male urine specimens as evidence of infection with C.
- Xpert Ct/NgK121710 · Cepheid · Dec 27, 2012
- Abbott M2000SP and Abbott M2000RT, Models 9K14-01 (G-Series), 9K14-02 (E-Series), 9K1501K092705 · Abbott Molecular, Inc. · May 28, 2010
- Abbott Realtime Ct/Ng and Abbott Multi-Collect Specimen Collection Kit, Models 8L07-91, 9K12-03K092704 · Abbott Molecular, Inc. · May 28, 2010
- Abbott Realtime Ct/Ng Assay and Multi-Collect Specimen Collection KitK080739 · Abbott Molecular, Inc. · Jul 10, 2008
- Aptima Neisseria gonorrhoeae AssayK231329 · Hologic, Inc. · Jan 26, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 25, 2001
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3390
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files